Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD

PALO ALTO, Calif.--(BUSINESS WIRE)--Spot Biosystems launches with $40M financing and world-first non-viral delivery of full-length dystrophin in animal models and human patients with DMD